期刊论文详细信息
Journal of Translational Medicine
Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification
Zhihong Huang1  Ping Mei1  Xue Jiang2  Huawen Li2  Zhixing Cao3  Mingbing Wang4  Huiqiong Bao4  Ligong Lu5  Li Chen6  Wenting Li7  Jiali Hu7  Hongwei Sun7  Xiaobin Li7  Meixiao Zhan8 
[1] Department of Gynaecology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China;Department of Gynecology, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China;Department of Pathology, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China;The Second School of Clinical Medicine, Southern Medical University, Department of Gynaecology, Guangzhou, China;Department of Gynaecology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China;The Second School of Clinical Medicine, Southern Medical University, Department of Gynaecology, Guangzhou, China;Zhuhai Precision Medical Center, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China;Center of Intervention Radiology, Zhuhai Precision Medicine Center, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, China;Zhuhai Center for Maternal and Child Health Care, Zhuhai Women and Childen’s Hospital, Zhuhai, China;Zhuhai Precision Medical Center, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China;Zhuhai Precision Medical Center, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China;Center of Intervention Radiology, Zhuhai Precision Medicine Center, Zhuhai People’s Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, China;
关键词: Cervical cancer;    Coatomer protein subunit alpha;    Immunohistochemistry;    Proteomics;    Tumor mechanism;   
DOI  :  10.1186/s12967-021-03218-1
来源: Springer
PDF
【 摘 要 】

BackgroundCervical cancer is the most fatal gynecological carcinoma in the world. It is urgent to explore novel prognostic biomarkers and intervention targets for cervical cancer.MethodsThrough integrated quantitative proteomic strategy, we investigated the protein expression profiles of cervical cancer; 28 fresh frozen tissue samples (11 adenocarcinoma (AC), 12 squamous cell carcinoma (SCC) and 5 normal cervixes (HC)) were included in discover cohort; 45 fresh frozen tissue samples (19 AC, 18 SCC and 8 HC) were included in verification cohort; 140 paraffin-embedded tissues samples of cervical cancer (85 AC and 55 SCC) were used for immunohistochemical evaluation (IHC) of coatomer protein subunit alpha (COPA) as a prognostic biomarker for cervical cancer; how deficiency of COPA affects cell viability and tumorigenic ability of cervical cancer cells (SiHa cells and HeLa cells) were evaluated by cell counting kit-8 and clone formation in vitro.ResultsWe identified COPA is a potential prognostic biomarker for cervical cancer in quantitative proteomics analysis. By retrospective IHC analysis, we additionally verified the proteomics results and demonstrated moderate or strong IHC staining for COPA is an unfavourable independent prognostic factor for cervical cancer. We also identified COPA is a potential pharmacological intervention target of cervical cancer by a series of in vitro experiments.ConclusionThis study is the first to demonstrate that COPA may contribute to progression of cervical cancer. It can serve as a potential prognostic biomarker and promising intervention target for cervical cancer.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202203115645282ZK.pdf 4157KB PDF download
  文献评价指标  
  下载次数:11次 浏览次数:0次